Aratana Therapeutics Inc (NASDAQ:PETX)

5.08
Delayed Data
As of Apr 20
 +0.11 / +2.21%
Today’s Change
3.67
Today|||52-Week Range
7.67
-3.42%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Aratana Therapeutics Inc have a median target of 8.00, with a high estimate of 10.00 and a low estimate of 6.00. The median estimate represents a +57.48% increase from the last price of 5.08.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Aratana Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.19
Sales
$5.9M
Reporting Date
May 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 49.81%
 
 
 
 
 
 
Growthannually 44.59%
 
 
 
 
 
 

Sales

Growthquarterly -43.42%
 
 
 
 
 
 
Growthannually 29.78%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.